Qiagen NV | QIA - Capital Social Ordinario





Capital Social Ordinario Cambio Fecha
Akebia Therapeutics USD 265.42M 199K 2025-12
Alaunos Therapeutics USD 2.49M 108K 2026-06
argenx SE USD 62.54M 2.74M 2026-06
Dianthus Therapeutics USD 54.8M 215.59K 2026-06
Ionis Pharmaceuticals USD 166.41M 773K 2026-09
IQVIA Holdings USD 164.8M 200K 2026-09
Moderna USD 391M 2M 2025-09
Organon & Co USD 262.62M 13K 2026-09
Qiagen NV USD 206.5M 245K 2026-06
Revvity USD 111.59M 43K 2026-09
Tectonic Therapeutic USD 19.24M 404.78K 2026-06
Viatris USD 1.15B 8.79M 2026-09
Xeris Pharmaceuticals USD 173.59M 1.03M 2026-06